Daily Archives: May 23, 2012


Roche Schizophrenia, MS Drugs Move to Final Stages of Clinical Testing – Bloomberg

This is a very positive development, if it holds up: A new medicine for schizophrenia that helps the negative symptoms…often the toughest to deal with in recovery. Schizophrenia Symptoms RG1678, a so-called glycine reuptake inhibitor, was effective in reducing the … Continue reading